Navigation Links
Pacira Pharmaceuticals Names David M. Stack CEO and President
Date:12/18/2007

SAN DIEGO, Dec. 18 /PRNewswire/ -- Pacira Pharmaceuticals, Inc., a leader in sustained release injectable technologies, today announced that David M. Stack has been selected as President, Chief Executive Office, and member of the Board of Directors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070618/PACIRALOGO)

Mr. Stack is currently the CEO and founding partner of Stack Pharmaceuticals, Inc., a commercialization, marketing and strategy firm serving emerging healthcare companies. He also is an Executive Partner at MPM Capital.

"David Stack is a proven, successful pharmaceutical executive with an exceptional blend of leadership and business skills," said Fred Middleton, Chairman of the Board. "We are confident that he is the ideal person to lead Pacira by enhancing the revenue opportunities of our existing commercial products, DepoDur and DepoCyt, optimizing the development and launch of our key asset, DepoBupivacaine, while further exploring the untapped promise of our proprietary drug delivery technologies."

Commenting on his appointment, Mr. Stack said, "I look forward to joining Pacira at this exciting time in its history. With strong financial backing by a pharmaceutical experienced syndicate, Pacira now has the opportunity to realize its potential by growing into a fully integrated, successful commercial company."

From September 2001 until August 2004, Mr. Stack was President, Chief Executive Officer and Director of The Medicines Company (Nasdaq: MDCO). Prior to The Medicines Company he was the CEO of Stack Pharmaceuticals, Inc. where MDCO was one of the primary customers.

From May 1995 to December 1999, Mr.
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 25, 2014 As reported by the New ... Marijuana Increasing (7/3), the state of Louisiana has recently ... so even than cocaine. Officials believe the increase is due ... a “form” of marijuana. However, both doctors and police confirm ... far as to call it “poison,” doctors have acknowledged that ...
(Date:7/25/2014)... Consuming too much salt? Overloaded on fats, sugars ... labels! , Learn to decipher the valuable information on ... during a "Healthy Eating for You: Label Reading" presentation ... Ohltown Road, Austintown. , Registered dietician and community educator ... questions. , The presentation is free and open ...
(Date:7/25/2014)... (GSA) the nation,s largest interdisciplinary organization devoted ... Heather M. Young, PhD, RN, FAAN, of the ... of the Doris Schwartz Gerontological Nursing Research Award. ... Sciences Section, is given to a member of ... contribution to gerontological nursing research. , The award ...
(Date:7/25/2014)... USA (PRWEB) July 25, 2014 As reported ... Use, OD Deaths Increase (7/20), Michigan has seen a nearly ... four years. While the count was 271 between 1999 and ... range. DEA Agents believe that, like other states, drug users ... the drug via prescription pills. He compared the price of ...
(Date:7/25/2014)... As reported by People Magazine in the article ... Getting Sober (7/15), one of the most popular cast ... to the public about his personal transformation. Now, two years ... that moving on with his life was a challenge. He ... in 2012 and even spent some time in rehab. He ...
Breaking Medicine News(10 mins):Health News:Louisiana Recognizes Dangers of Synthetic Marijuana 2Health News:Learn to Decipher Food Labels at Humility House 2Health News:Young earns GSA's 2014 Doris Schwartz Gerontological Nursing Research Award 2Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2Health News:'The Situation' Celebrates 8 Months of Sobriety 2Health News:'The Situation' Celebrates 8 Months of Sobriety 3
... of AED Improves Survival Rates. , ... Rosemont, IL (Vocus) December 30, ... comprehensive emergency action plan (EAP) at an athletic event can mean the ... Cardiac Arrest (SCA) , confirms a study published in the inaugural edition ...
... registered its one-millionth member just 14 months after its launch last ... a more active role in managing their own healthcare. ... ... -- Helping Patients and Physicians , , , "Despite enormous ...
... American Scientific Resources, Inc. (Pink Sheets: ASFX), today announced the ... directors: Mr. Felix Reznick and Ms. Teresa McWilliams, American ... Boston College Law School and the New York ... Boston College Law School (J.D. 1998), and was ...
... 30 Delcath Systems, Inc. (Nasdaq: DCTH ... quarterly update conference call at 4:30 PM Eastern Time ... Chief Executive Officer of Delcath Systems, will host the ... patient enrollment and the advancement of clinical studies. ...
... can revitalize a company or a sports team. Recent research ... body good as well, especially when it comes to fighting ... from the Department of Psychology,s Neuroimmunology Research Unit, discovered that ... stored for less than 9 days increased the odds ...
... Jr., chairman and chief executive officer, Medco Health Solutions, Inc. ... Goldman Sachs Healthcare CEOs Unscripted: A View from the Top ... presentation will begin at 11:15 a.m. EST and Richard J. ... Additionally, Snow will participate on a CEO panel, "Tackling the ...
Cached Medicine News:Health News:Study Stresses Importance of Availability of Automated External Defibrillators at Athletic Events 2Health News:Study Stresses Importance of Availability of Automated External Defibrillators at Athletic Events 3Health News: One Million Americans Now Receive Personalized FDA Drug Safety Alerts Through iGuard.org 2Health News: One Million Americans Now Receive Personalized FDA Drug Safety Alerts Through iGuard.org 3Health News:American Scientific Resources Announces Addition of New Board Members 2Health News:Delcath Systems to Host Quarterly Update Conference Call 2Health News:Delcath Systems to Host Quarterly Update Conference Call 3Health News:Young blood fights cancer 2Health News:Young blood fights cancer 3Health News:Medco CEO to Present at the 2009 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conference 2
(Date:7/25/2014)... 25, 2014  Semler Scientific, Inc. (Nasdaq: ... assessment company that develops patented products that assist ... diseases, today reported financial results for the second ... "The second quarter of 2014 ... Doug Murphy-Chutorian , M.D., chief executive officer of ...
(Date:7/25/2014)... SAN DIEGO , July 25, 2014  Arena ... it will provide a corporate update and report second ... Market opens on Friday, August 1, 2014. That same ... at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time). ... by dialing 877.643.7155 for domestic callers and 914.495.8552 for ...
(Date:7/24/2014)... PARK, Kan. , July 24, 2014 /PRNewswire/ ... of two compounds that will be added to ... with Australian-based CIMTECH Pty Ltd, a biotechnology company. ... PAR 122 have shown promise in bone regeneration ... license to develop the compounds for the veterinary ...
Breaking Medicine Technology:Semler Reports Second Quarter 2014 Financial Results 2Semler Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4
... , May 20 As the medical device industry gathers ... of Sales Content Management software, offers medical device companies a solution to ... , , ... Sciences at Prolifiq, will lead the workshop "Sales-Friendly Compliant Content Communication: How ...
... NEW YORK , May 19 ... stage, specialty pharmaceutical and medical device company focused on ... Oncology (ASCO) has accepted an oral presentation of Delcath,s ... (PHP-mel) to the best alternative care for patients with hepatic ...
Cached Medicine Technology:Prolifiq Offers Best Practices Solution for Selling Medical Devices in Tough Regulatory Environment 2Prolifiq Offers Best Practices Solution for Selling Medical Devices in Tough Regulatory Environment 3Delcath Reconfirms Presentation During American Society of Clinical Oncology 2010 Annual Meeting in Chicago 2Delcath Reconfirms Presentation During American Society of Clinical Oncology 2010 Annual Meeting in Chicago 3
... Rusch Safety Clear Plus™ Cuffed Endotracheal Tube ... stylet inside. Sterile, Single use. A quality Rusch ... ready to use saving you time and storage ... to facilitate smooth withdrawal. It is designed with ...
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. Murphy eye. High volume/low pressure cuff. Connector is permanently fixed into the tube. X-ray opaque. Graduated. Single use. Steri...
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
... with Murphy eye. Laser resistant foam surrounds the ... (One inside other) 40cm (16") long, Single Use. ... access and optimum visibility within the operating site, ... a special laser-guard of approx. 17cm in length ...
Medicine Products: